#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Acute graft versus host disease in intestine Anti-myelin-associated glycoprotein antibodies positive Autoinflammation with infantile enterocolitis Turner's syndrome Adenovirus infection Autoimmune disorder Prophylaxis against transplant rejection Hepatic angiosarcoma Marginal zone lymphoma refractory Myxofibrosarcoma Sarcoidosis Blood iron increased Pseudoxanthoma elasticum Glomerulonephritis More trials…

    Learn about Rare Diseases

    MELAS syndrome – Diagnostics Vascular malformation – Diagnostics Pemphigoid – Trials in Disease Haemolytic uraemic syndrome – Diagnostics Ocular melanoma – Diagnostics Fragile X syndrome – Trials in Disease Pleural mesothelioma malignant – Basic Information Mantle cell lymphoma stage IV – Treatment Osteosarcoma metastatic – Life with Disease Hairy cell leukaemia recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lithium Carbonate Levodopa Tominersen Specific Nucleic Acid Sna-Veru Imatinib Savolitinib Amcenestrant Ketamine Hydrochloride Cefoxitin Methylprednisolone Aceponate Prs-344 VRDN-003 Fenfluramine Hydrochloride Falbikitug Nipocalimab Mirtazapine Sodium Butyrate Adagrasib Deferiprone BMS-986365 More therapies…

    Learn about Your Condition

    Pancreatic carcinoma recurrent Incontinence Gingival bleeding Lipid metabolism disorder Duchenne muscular dystrophy Anogenital warts HER2 negative breast cancer Portal hypertension Joint stabilisation Palmoplantar pustulosis Dermatomyositis Rectosigmoid cancer Advanced systemic mastocytosis Ataxia telangiectasia EGFR gene mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Long-term safety study of oral etavopivat tablets in children, adolescents and adults with sickle cell disease or thalassaemia who completed previous etavopivat treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell disease
    • Thalassaemia
    Investigated Drugs:
    • Etavopivat
    France Germany Greece Italy Spain

  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Busulfan
    • Dinutuximab Beta
    • Melphalan
    Austria Belgium Czechia Denmark Finland France +13

  • Study of Elafibranor for Adults with Primary Biliary Cholangitis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Elafibranor
    Belgium Bulgaria Czechia Denmark France Greece +8

  • Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Systemic scleroderma
    Investigated Drugs:
    • Belimumab
    Belgium Denmark Finland France Germany Greece +2

  • Study on the Safety and Effectiveness of Lufepirsen Gel for Patients with Persistent Corneal Epithelial Defects

    Recruiting

    2 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Lufepirsen
    France Germany Italy Spain

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daunorubicin
    • Mercaptopurine
    • Methotrexate Sodium
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

    Recruiting

    2 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
    Austria Croatia Finland Germany Ireland Italy +5

  • Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Drugs:
    • Emtricitabine
    • Entecavir
    • Ianalumab
    Bulgaria Czechia France Germany Hungary Italy +5

  • Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Ibrutinib
    • Zanubrutinib
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Morf-057
    Austria Bulgaria Croatia Czechia Estonia France +8
Previous Page
1 … 11 12 13 14 15 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!